4th Circ. Frees Pfizer From Antitrust Suit Over Celebrex Patent
The Fourth Circuit on Thursday granted an unopposed motion to dismiss an antitrust suit brought against Pfizer Inc. by a putative class of health benefits plans that alleged the company used...To view the full article, register now.
Already a subscriber? Click here to view full article